(Q43968416)

28 November 2017

title

Pain, sedation and morphine metabolism in cancer patients during long-term treatment with sustained-release morphine (English)

1 reference

28 November 2017

1 reference

Lona Louring Christrup

3

1 reference

28 November 2017

G Andersen

1

1 reference

28 November 2017

N H Jensen

2

1 reference

28 November 2017

S H Hansen

4

1 reference

28 November 2017

P Sjøgren

5

1 reference

28 November 2017

language of work or name

1 reference

1 March 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

16

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

107-114

1 reference

Pharmacokinetics and analgesic effect of slow-release oral morphine sulphate in volunteers

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

Morphine and morphine-glucuronide concentrations in plasma and CSF during long-term administration of oral morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

Morphine metabolism in cancer patients on increasing oral doses--no evidence for autoinduction or dose-dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

Oral morphine in cancer pain: influences on morphine and metabolite concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

Morphine-3-glucuronide--a potent antagonist of morphine analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

Chronic morphine therapy for cancer pain: plasma and cerebrospinal fluid morphine and morphine-6-glucuronide concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

The analgesic activity of morphine-6-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

Concentrations of morphine and morphine metabolites in CSF and plasma during continuous subcutaneous morphine administration in cancer pain patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

CSF and plasma concentrations of morphine and morphine glucuronides in cancer patients receiving epidural morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

Morphine and dryness of the mouth

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

A validation study of the WHO method for cancer pain relief

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

The metabolism and bioavailability of morphine in patients with severe liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

Steady-State Kinetics and Dynamics of Morphine in Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0269216302PM512OA

10.1191/0269216302PM512OA

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference